BlackRock, Inc. 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 5:28 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
BlackRock Inc. BLK |
5,743,482 6.800% |
1,044,711 (+22.23%) |
Filing |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
BlackRock Inc. BLK |
4,698,771 5.600% |
0 (Unchanged) |
Filing |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
BlackRock Inc. BLK |
4,698,771 5.600% |
1,577,906 (+50.56%) |
Filing |
| 2024-06-07 1:30 pm Sale |
2024-05-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
BlackRock Inc. BLK |
3,120,865 4.800% |
-288,113 (-8.45%) |
Filing |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
BlackRock Inc. BLK |
3,408,978 5.500% |
3,408,978 (New Position) |
Filing |